Skip to content

EFFECT OF WEIGHT LOSS ON IRON STATUS

EFFECT OF WEIGHT LOSS ON IRON STATUS AMONG OVERWEIGHT AND OBESE YOUNG JORDANIAN WOMEN WITH IRON DEFICIENCY ANEMIA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20221009001
Enrollment
62
Registered
2022-10-09
Start date
2020-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron status among overweight and obese young women with iron deficiency anemia. Weight Loss

Interventions

The intervention duration was three months. The intervention group received individual consultation sessions with the dietitian on days 0, 15, 30, 45, 60, and 75 for 30 minutes. During the consultatio
Experimental Behavioral,No Intervention No treatment
Weight Loss,Control

Sponsors

Main Researcher (Naseem Alshwaiyat; PhD Candidate)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Jordanian citizenship Arab ethnicity Female Young adult (aged 18-30 years old) Being overweight or obese Had iron deficiency anemia

Exclusion criteria

Exclusion criteria: Symptomatic patients with common iron deficiency anemia signs and symptoms Pregnancy or lactation within the past 12 months Self-report for the presence of significant medical conditions Vegetarianism Tobacco smoking Alcohol drinking Drug abuse Had unstable body weight within the past 6 months Irregular menstrual cycle (void of at least one menstrual cycle within the past 12 months) Undergo bariatric surgery Undergo full or partial hysterectomy Donate blood or history of hemorrhage within the past 6 months Consume iron supplementation within the past 6 months Consume any dietary supplementations other than iron within the past 3 months Use of medications that may influence weight, iron, or inflammatory status such as contraceptive medication within the past 3 months

Design outcomes

Primary

MeasureTime frame
Iron status markers At days 0 and 90 of trial commencement Blood analysis

Secondary

MeasureTime frame
high sensitivity C-reactive protein and hepcidin At days 0 and 90 of trial commencement Blood analysis

Countries

Jordan

Contacts

Public ContactNaseem Alshwaiyat

Faculty of Health Sciences, Universiti Sultan Zainal Abidin

si3346@putra.unisza.edu.my00601133321410

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026